Chinese researchers reverse type 1 diabetes using a patient’s own stem cells
Type 1 diabetes reversal using a patient’s own stem cells marks a historic milestone in medicine. A 25-year-old woman in China received a transplant of insulin-producing cells reprogrammed from her own body, and within three months was generating insulin naturally — eventually eliminating her need for external injections entirely. Published in Cell in 2024, the research is significant because it bypasses donor tissue and immunosuppressant drugs entirely, dramatically reducing rejection risk. For the roughly 8.4 million people worldwide living with type 1 diabetes, this proof of concept offers a genuinely new direction for treatment.








